News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ARYx Therapeutics, Inc. to Transfer to the NASDAQ Capital Market


12/21/2010 9:23:53 AM

FREMONT, Calif.--(BUSINESS WIRE)--ARYx Therapeutics, Inc. (NASDAQ:ARYX) today announced that it has been notified by The NASDAQ Stock Market (“NASDAQ”) that the listing of its common stock will be transferred from The NASDAQ Global Market to The NASDAQ Capital Market effective with the open of business today, December 21, 2010. As previously announced on October 8, 2010, following notice of non-compliance with the NASDAQ stockholders’ equity requirement for continued listing on The NASDAQ Global Market, ARYx requested a hearing before a NASDAQ Listing Qualifications Panel (the “Panel”). The NASDAQ decision to transfer ARYx’s securities to The NASDAQ Capital Market follows the hearing with the Panel in November and the Panel’s review of additional information, including the information contained in the Company’s press release dated December 15, 2010.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES